Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20‐year nationwide cohort study
Open Access
- 5 February 2025
- journal article
- cancer epidemiology
- Published by Wiley in International Journal of Cancer
- Vol. 157 (2) , 218-231
Abstract
Small intestinal adenocarcinomas (SIAs) are associated with predisposing conditions, including inflammatory bowel disease (IBD) and celiac disease, but also genetic syndromes such as Lynch syndrome (LS) and familial adenomatous polyposis (FAP). This nationwide cohort study investigated the incidence of genetic and non‐genetic predisposing conditions in SIA and their influence on tumor characteristics and clinical features. Data were obtained from the Netherlands Cancer Registry. The incidence, characteristics, and clinical features per predisposing condition were analyzed in 2697 SIA patients diagnosed from 1999 through 2019. Of all SIA patients, 5.6% were known to have a genetic predisposing syndrome, of whom 4.0% had LS and 1.6% had a polyposis syndrome. In addition, 6.8% of SIA patients had a non‐genetic predisposing condition: 3.9% IBD and 2.9% celiac disease. SIAs of patients with such predisposing syndromes or conditions were diagnosed at a younger age and earlier stage and affected the duodenum less often as compared to sporadic SIA patients. Both genetic and non‐genetic predisposing conditions were associated with significantly better overall survival (OS) compared to sporadic SIA: sporadic SIA (median OS: 13.0 months, 95% CI: 11.8–14.2), LS (213.1 months, 99.3–NA), polyposis syndromes (61.3 months, 19.7–NA), IBD (29.5 months, 20.3–69.8), and celiac disease (50.4 months, 24.6–124.7). This nationwide cohort study shows significant differences between SIA with and without predisposing conditions and highlights the need for research on underlying molecular mechanisms to improve outcomes of SIA patients.Keywords
Funding Information
- KWF Kankerbestrijding (KWF 14182)
- ZonMw (Vici 09‐15018‐21‐10029)
- European Research Council (ERC‐CoG 101045612 ‐ NIMICRY)
- New York Stem Cell Foundation (NYSCF‐I‐R43)
- Oncode Institute
This publication has 49 references indexed in Scilit:
- Gastric and duodenal cancer in individuals with Lynch syndrome: a nationwide cohort studyeClinicalMedicine, 2024
- Evaluation of Systemic Treatments of Small Intestinal AdenocarcinomasJAMA Network Open, 2023
- Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD‐NADEGE cohort study of 347 patientsInternational Journal of Cancer, 2020
- Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis RegistryClinical Gastroenterology and Hepatology, 2019
- Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatmentDigestive and Liver Disease, 2014
- Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002European Journal of Cancer, 2012
- Small bowel endoscopy in familial adenomatous polyposis and Lynch syndromeBest Practice & Research Clinical Gastroenterology, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- A single-institution experience with 491 cases of small bowel adenocarcinomaThe American Journal of Surgery, 2010
- Small-Bowel TumorsArchives of Surgery, 2007